Jing Liang

Jing Liang's research focuses on cancer immunology and the tumor immune microenvironment, with particular attention to how treatments like microwave ablation, CDK4/6 inhibitors, and immune checkpoint inhibitors affect anti-tumor immune responses in cancers such as colorectal, breast, and lung cancer. The work also touches on related topics including tumor microbiota, ischemic stroke metabolism, and case reports on immunotherapy side effects, reflecting a broad translational and clinical oncology focus.

Publication output has grown from occasional papers before 2020 to a steadier pace of 3-5 papers per year since 2023, suggesting an increasing and relatively active research output over the past decade.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026